Breast Neoplasm - Miscellaneous
NCT01382082
Clinical Trial Information
Trial Number: NCT01382082 (ClinicalTrials.gov)
Disease Type:
- Breast Neoplasm - Miscellaneous
- Hematopoietic Neoplasm/Lymphoma - Miscellaneous
Trial Title:
Assessment of Cognitive Function in Breast Cancer and Lymphoma Patients Receiving Chemotherapy at Pre-Treatment, Post-Treatment, at Six Month Follow-Up, and Long-Term Follow-Ups
Study ID:
URCC-10055
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
NCT01224678
Clinical Trial Information
Trial Number: NCT01224678 (ClinicalTrials.gov)
Disease Type:
- Breast Neoplasm - Miscellaneous
- Non-neoplastic Disorder - Miscellaneous
Trial Title:
Vitamin D and Breast Cancer Biomarkers
Study ID:
CALGB-70806
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
Title | Description |
---|---|
NCT01224678-D2 | Dataset NCT01224678-D2-Dataset.csv (aedat) is one of 2 datasets associated with PubMed ID 33849913. This dataset contains data presented in the safety analyses. |
NCT01224678-D1 | Dataset NCT01224678-D1-Dataset.csv (rand) is one of 2 datasets associated with PubMed ID 33849913. This dataset contains data presented in the publication other than the safety analyses. |
NCT02115282
Clinical Trial Information
Trial Number: NCT02115282 (ClinicalTrials.gov)
Disease Type:
- Breast Neoplasm - Breast Cancer (Invasive)
- Breast Neoplasm - Miscellaneous
Trial Title:
A Randomized Phase III Trial of Endocrine Therapy Plus Entinostat/Placebo in Patients With Hormone Receptor-Positive Advanced Breast Cancer
Study ID:
E2112
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
Title | Description |
---|---|
NCT02115282-D2 | There are two submissions for PMID 34357781. This dataset, NCT02115282-D2, contains toxicity data. Dataset NCT02115282-D1 contains baseline, treatment, and efficacy data |
NCT02115282-D1 | There are two submissions for PMID 34357781. This dataset, NCT02115282-D1, contains baseline, treatment, and efficacy data. Dataset NCT02115282-D2 contains toxicity data. |
NCT01573442
Clinical Trial Information
Trial Number: NCT01573442 (ClinicalTrials.gov)
Disease Type:
- Breast Neoplasm - Miscellaneous
Trial Title:
Randomized Double-Blind Placebo Controlled Study of Testosterone in the Adjuvant Treatment of Postmenopausal Women With Aromatase Inhibitor Induced Arthralgias
Study ID:
A221102
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
Title | Description |
---|---|
NCT01573442-D14 | Dataset NCT01573442-D14-Dataset.csv (supplemental3) is one of 14 datasets associated with PubMed ID 32372176. This dataset contains data presented in Supplemental Table S3. |
NCT01573442-D13 | Dataset NCT01573442-D13-Dataset.csv (gene_analysis) is one of 14 datasets associated with PubMed ID 32372176. This dataset contains data presented in the genetic polymorphism, distribution of variants, and genetic associations portions of the manuscript. |
NCT01573442-D12 | Dataset NCT01573442-D12-Dataset.csv (figure_supplemental) is one of 14 datasets associated with PubMed ID 32372176. This dataset contains data presented in the supplemental figures. |
NCT01573442-D11 | Dataset NCT01573442-D11-Dataset.csv (subcut) is one of 14 datasets associated with PubMed ID 32372176. This dataset contains information on patients receiving subcutaneous treatment. |
NCT01573442-D10 | Dataset NCT01573442-D10-Dataset.csv (hotflash_sub) is one of 14 datasets associated with PubMed ID 32372176. This dataset contains information on hot flash scores for patients receiving subcutaneous treatment. |
NCT01573442-D9 | Dataset NCT01573442-D9-Dataset.csv (Hotflash) is one of 14 datasets associated with PubMed ID 32372176. This dataset contains information on hotflash frequency and scores per week. |
NCT01573442-D8 | Dataset NCT01573442-D8-Dataset.csv (supplemental2) is one of 14 datasets associated with PubMed ID 32372176. This dataset contains data presented in supplemental table S2. |
NCT01573442-D7 | Dataset NCT01573442-D7-Dataset.csv (sed) is one of 14 datasets associated with PubMed ID 32372176. This dataset contains information on the symptom experience diary (SED). |
NCT01573442-D6 | Dataset NCT01573442-D6-Dataset.csv (qol3) is one of 14 datasets associated with PubMed ID 32372176. This dataset contains data on the HFRDIS and POMS QoL analyses. |
NCT01573442-D5 | Dataset NCT01573442-D5-Dataset.csv (figure2) is one of 14 datasets associated with PubMed ID 32372176. This dataset contains data presented in Figure 2 in the manuscript, the BPI average pain scores per month. |
NCT01385137
Clinical Trial Information
Trial Number: NCT01385137 (ClinicalTrials.gov)
Disease Type:
- Breast Neoplasm - Miscellaneous
Trial Title:
S0927: A Randomized Placebo-Controlled Trial of Omega-3-Fatty Acid for the Control of Aromatase Inhibitor-Induced Musculoskeletal Pain and Stiffness In Women With Early Stage Breast Cancer, Phase III
Study ID:
S0927
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
NCT01535066
Clinical Trial Information
Trial Number: NCT01535066 (ClinicalTrials.gov)
Disease Type:
- Breast Neoplasm - Miscellaneous
Trial Title:
Randomized Blinded Sham- and Waitlist-Controlled Trial of Acupuncture for Joint Symptoms Related to Aromatase Inhibitors in Women With Early Stage Breast Cancer
Study ID:
S1200
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
Title | Description |
---|---|
NCT01535066-D2 | There are two datasets for PMID 29998338 to reproduce the results of the treatment comparison of true acupuncture, sham acupuncture and waitlist control on AI related joint pain. This dataset, NCT01535066-D2, contains toxicity data. |
NCT01535066-D1 | There are two datasets for PMID 29998338 to reproduce the results of the treatment comparison of true acupuncture, sham acupuncture and waitlist control on AI related joint pain. This dataset, NCT01535066-D1, contains baseline characteristic and patient-reported questionnaire data. |
NCT00869206
Clinical Trial Information
Trial Number: NCT00869206 (ClinicalTrials.gov)
Disease Type:
- Breast Neoplasm - Miscellaneous
- Hematopoietic Neoplasm/Myeloma - Myeloma
- Reproductive System Neoplasm, Male - Prostate Cancer
Trial Title:
A Randomized, Phase III Study of Standard Dosing Versus Longer Dosing Interval of Zoledronic Acid in Metastatic Cancer
Study ID:
CALGB-70604
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
Title | Description |
---|---|
NCT00869206-D10 | Dataset NCT00869206-D10-Dataset.csv (delay) is one of 10 datasets associated with PubMed ID 28030702. This dataset contains information for the adherence to treatment by group. |
NCT00869206-D9 | Dataset NCT00869206-D9-Dataset.csv (incsre) is one of 10 datasets associated with PubMed ID 28030702. This dataset contains information for the types of skeletal-related events by treatment group. |
NCT00869206-D8 | Dataset NCT00869206-D8-Dataset.csv (bonedems1) is one of 10 datasets associated with PubMed ID 28030702. This dataset contains information for the baseline characteristics table for C-telopeptide companion study. |
NCT00869206-D7 | Dataset NCT00869206-D7-Dataset.csv (renal) is one of 10 datasets associated with PubMed ID 28030702. This dataset contains information for the osteonecrosis of the jaw, kidney dysfunction, and skeletal morbidity rate secondary endpoints. There is a difference in our SRE follow-up time to what was in the manuscript due to updated data. |
NCT00869206-D6 | Dataset NCT00869206-D6-Dataset.csv (pscmh) is one of 10 datasets associated with PubMed ID 28030702. This dataset contains information for the Performance status secondary endpoint and supplemental figure. |
NCT00869206-D5 | Dataset NCT00869206-D5-Dataset.csv (bpigrowth) is one of 10 datasets associated with PubMed ID 28030702. This dataset contains information for the BPI Secondary Endpoints and the supplemental figures. |
NCT00869206-D4 | Dataset NCT00869206-D4-Dataset.csv (master_bone) is one of 10 datasets associated with PubMed ID 28030702. This dataset contains the information in the figure of Mean C-Telopeptide levels by treatment group at each week. |
NCT00869206-D3 | Dataset NCT00869206-D3-Dataset.csv (ske_events) is one of 10 datasets associated with PubMed ID 28030702. This dataset contains information for the skeletal-related events by disease site and cause-specific cumulative incidence of skeletal-related events. There are differences in the numbers that produced the CIF graph due to updated data. Specifically, the data for the time variable (sre_mos) and number of patient deaths (OF001 in D1 dataset = “Death on Study”) provided in this submission are the correct data and will not match the publication exactly. |
NCT00869206-D2 | Dataset NCT00869206-D2-Dataset.csv (patchar) is one of 10 datasets associated with PubMed ID 28030702. This dataset contains information in the baseline characteristics table. |
NCT00869206-D1 | Dataset NCT00869206-D1-Dataset.csv (consort) is one of 10 datasets associated with PubMed ID 28030702. This dataset contains information in the Consort Diagram. |
NCT00002920
Clinical Trial Information
Trial Number: NCT00002920 (ClinicalTrials.gov)
Disease Type:
- Breast Neoplasm - Miscellaneous
Trial Title:
A Randomized Comparison Of Medroxyprogesterone Acetate (MA) And Observation For Prevention Of Endometrial Pathology In Postmenopausal Breast Cancer Patients Treated With Tamoxifen, Phase III
Study ID:
S9630
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
Title | Description |
---|---|
NCT00002920-D2 | NCT00002920-D1 and -D2 contain the data presented in NPJ Breast Cancer (Potkul et al., NPJ, 2016; PMID 28721383). This dataset, NCT00002920-D2, contains event-level information (one row per patient per adverse event experienced on trial). |
NCT00002920-D1 | NCT00002920-D1 and -D2 contain the data presented in NPJ Breast Cancer (Potkul et al., NPJ, 2016; PMID 28721383). This dataset, NCT00002920-D1, contains patient-level data (one row per patient), including eligibility, evaluability, treatment, demographic, and baseline information. It also contains assessment data. |
NCT00365105
Clinical Trial Information
Trial Number: NCT00365105 (ClinicalTrials.gov)
Disease Type:
- Breast Neoplasm - Miscellaneous
- Lung, Mediastinal and Pleural Neoplasm - Miscellaneous
- Reproductive System Neoplasm, Male - Prostate Cancer
Trial Title:
Randomized Phase III Trial to Evaluate Radiopharmaceuticals and Zoledronic Acid in the Palliation of Osteoblastic Metastases From Lung, Breast, and Prostate Cancer
Study ID:
RTOG-0517
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
Title | Description |
---|---|
NCT00365105-D2 | Data submissions NCT00365105-D1 and NCT00365105-D2 contain patient-reported acute toxicity and health-related quality of life (QOL) data from trial NCT00365105 to reproduce results PubMed ID=30094545. |
NCT00365105-D1 | Data submissions NCT00365105-D1 and NCT00365105-D2 contain patient-reported acute toxicity and health-related quality of life (QOL) data from trial NCT00365105 to reproduce results PubMed ID=30094545. |
NCT01376349
Clinical Trial Information
Trial Number: NCT01376349 (ClinicalTrials.gov)
Disease Type:
- Breast Neoplasm - Miscellaneous
- Reproductive System Neoplasm, Female - Miscellaneous
Trial Title:
Vaginal DHEA for Vaginal Symptoms: A Phase III Randomized, Double Blind, Placebo- Controlled Trial
Study ID:
NCCTG-N10C1
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
Title | Description |
---|---|
NCT01376349-D6 | Dataset NCT01376349-D6-Dataset.csv (AE) is one of 6 datasets associated with PubMed ID 28921241. This dataset contains all reported adverse events during treatment. |
NCT01376349-D5 | Dataset NCT01376349-D5-Dataset.csv (table3) is one of 6 datasets associated with PubMed ID 28921241. This dataset contains information that will allow you to reproduce Table 3. Mean scores and change from baseline for select Female Sexual Function Index (FSFI) subscales and quality of life (QOL). |
NCT01376349-D4 | Dataset NCT01376349-D4-Dataset.csv (table2) is one of 6 datasets associated with PubMed ID 28921241. This dataset contains information that will allow you to reproduce Table 2. Change from Baseline to 12 weeks in self-reported side effects. Negative changes indicate worsening symptoms. |
NCT01376349-D3 | Dataset NCT01376349-D3-Dataset.csv (table1) is one of 6 datasets associated with PubMed ID 28921241. This dataset contains information that will allow you to reproduce Table 1. Baseline demographic and treatment characteristics. |
NCT01376349-D2 | Dataset NCT01376349-D2-Dataset.csv (figure2) is one of 6 datasets associated with PubMed ID 28921241. This dataset contains information that will allow you to reproduce Figure 2, the mean change in severity of dryness or dyspareunia over 12 weeks. |
NCT01376349-D1 | Dataset NCT01376349-D1-Dataset.csv (consort) is one of 6 datasets associated with PubMed ID 28921241. This dataset contains information regarding whether patients were included in the primary analysis. At the time of publication, 353 (Placebo=118; DHEA 3.25 mg=123; DHEA 6.5 mg=112) patients were used in the primary analysis. The updated data in NCT01376349-D1-Dataset includes a variable ‘endpoint’ which identifies which patients are currently evaluable for the primary endpoint based on updated data. This includes 344 (Placebo=108; DHEA 3.25 mg=123; DHEA 6.5 mg=113). |
Accessibility | Disclaimer | FOIA | HHS Vulnerability Disclosure | Privacy & Security
U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov
NIH…Turning Discovery Into Health®